LUXEMBURG–(BUSINESS WIRE)– Eurofins Technologies kondigt de lancering aan van de VIRSeek SARS-CoV-2 Mplex I en Mplex II Wastewater realtime RT-PCR-kits om een efficiënte oplossing te bieden voor SARS-CoV-2-detectie in afvalwater, inclusief de Omicron variant van zorg.

Op afvalwater gebaseerde epidemiologie is een belangrijke benadering geworden om het profiel van SARS-CoV-2-infecties in dichtbevolkte gebieden uitgebreid te volgen. Methoden om SARS-CoV-2 viraal RNA in onbehandeld afvalwater te detecteren, zijn de afgelopen maanden vooruitgegaan. Gegevens hebben aangetoond dat concentraties van viraal RNA correleren met trends in gerapporteerde COVID-19-gevallen, wat het belang aantoont van afvalwatertests als hulpmiddel voor de volksgezondheid.

Eurofins Technologies Launches Wastewater Diagnostic Kit for SARS-CoV-2 Testing Including Identification of Omicron Variant

LUXEMBOURG–(BUSINESS WIRE)– Eurofins Technologies announces the launch of the VIRSeek SARS-CoV-2 Mplex I and Mplex II Wastewater real-time RT-PCR kits to provide an efficient solution for SARS-CoV-2 detection in wastewater, including the Omicron variant of concern.

Wastewater-based epidemiology has become an important approach in order to comprehensively monitor the profile of SARS-CoV-2 infections in highly populated areas. Methods to detect SARS-CoV-2 viral RNA in untreated wastewater have advanced over the last number of months. Data has shown that concentrations of viral RNA correlate with trends in reported COVID-19 cases, demonstrating the importance of wastewater testing as a public health tool.

The European Commission has recommended¹ the implementation of effective systems for the surveillance of SARS-CoV-2 in wastewater. The VIRSeek SARS-CoV-2 Mplex I and Mplex II Wastewater real-time RT-PCR kits delivers an effective solution for SARS-CoV-2 detection in wastewater. The VIRSeek SARS-CoV-2 Wastewater kits detects genes to specifically identify SARS-CoV-2 together with primer/probes sets to evaluate process parameters such as the nucleic acid extraction efficiency, a specific water quality indicator or the impact of matrix inhibition via an internal positive control. The solution is intended to be used by analytical laboratories for SARS-CoV-2 analysis in wastewater samples as part of quality control/quality assurance testing.

These new members of the VIRSeek real-time RT-PCR kit-family for SARS-CoV-2 detection enhance Eurofins Technologies’ VIRSeek SARS-CoV-2 Solution offering by also enabling the detection of mutant variants such as the Omicron variant of concern. The VIRSeek real-time RT-PCR kit-family also incorporates viral concentration workflow and subsequent lysis and isolation of the viral SARS-CoV-2 RNA, using the VIRSeek RNAExtractor AE1 kit for automated platforms.

More information on Eurofins Technologies website.

About Eurofins Technologies – a fast growing provider of diagnostic technologies in the field of immunoassays and molecular detection methods

Building on the experience and scientific excellence of the Eurofins Group, Eurofins Technologies is a fast growing global provider of diagnostic technologies and industry-leading ELISA-based instruments in the field of bioanalytical testing for the food, feed, environmental, animal health, and clinical diagnostics industries.

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With 55,000 staff across a network of 900 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

¹ https://eur-lex.europa.eu/eli/reco/2021/472/oj

View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005084/en/

Contacts

Dr. Nadine Göhring

ir@eurofins.com